Collectively, 7 large commercial laboratories reported testing ≈2.4 million patient specimens for evidence of B. burgdorferi infection during 2008, at an estimated cost of $492 million.
The team examined the specimens for evidence of "intersex" gonads testes that produce egg cells or the presence of both a testicle and an ovary which are known effects of endocrine disruptor exposure.
The present study did not specifically assess the resected specimens for evidence of steatosis, unlike the MD Anderson study, which found an increased incidence of steatosis in those patients who had had preoperative chemotherapy, most marked in those who had received irinotecan.
The CDC laboratories in Atlanta evaluated tissue specimens for evidence of OPXV and MPXV (by using a polymerase chain reaction [PCR] and virus culture) and assayed blood specimens for antibodies (by using an enzyme-linked immunosorbent assay [ELISA]).
The current major method for assessing the risk of metastatic recurrence and need for adjuvant chemotherapy is to examine tumor resection specimens for evidence of metastasis to local lymph nodes.
A more extensive investigation of the specimen for evidence of infectious causes, such as mycobacterium tuberculosis and cytomegalovirus, and for non-infectious causes, such as malignancy, inflammatory bowel disease and systemic vasculitis were non-revealing.
At visual inspection of the specimens, no evidence of previous elbow injury in any of the tested elbow pairs was found.
Interestingly, final standardized pathological evaluation of TG specimens showed evidence of diffuse/signet-ring-cell carcinoma in 22 of 23 (96%) patients.
Over three-quarters of serum specimens had evidence of recent exposure, and this exposure persisted across the spectrum of age, sex and socioeconomic status.
The identification of juvenile specimens of Pentecopterus provides evidence for an unusual degree of postembryonic appendage differentiation in eurypterids.
